PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer

por Xiaoting Li, Tian Fang, Sen Xu, Ping Jin, Dongchen Zhou, Zhengzheng Wang, Huayi Li, Zongyuan Yang, Gang Chen, Xu Zheng, Yu Xia, Xiao Wei, Zeyu Zhang, Xin Yang, Ya Wang, Qinglei Gao
Publicado 2021